These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8389008)

  • 21. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effects and mechanism of action of sumatriptan in migraine.
    Ferrari MD; Saxena PR
    Clin Neurol Neurosurg; 1992; 94 Suppl():S73-7. PubMed ID: 1320526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurogenic inflammation in primary headaches.
    Fusco M; D'Andrea G; Miccichè F; Stecca A; Bernardini D; Cananzi AL
    Neurol Sci; 2003 May; 24 Suppl 2():S61-4. PubMed ID: 12811594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Goadsby PJ; Edvinsson L
    Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain mechanisms underlying vascular headaches. Progress Report 1989.
    Moskowitz MA; Buzzi MG; Sakas DE; Linnik MD
    Rev Neurol (Paris); 1989; 145(3):181-93. PubMed ID: 2664974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
    Bolay H; Reuter U; Dunn AK; Huang Z; Boas DA; Moskowitz MA
    Nat Med; 2002 Feb; 8(2):136-42. PubMed ID: 11821897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action of zolmitriptan].
    Pascual J
    Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutics of migraine.
    Welch KM
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):264-9. PubMed ID: 8386957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiopathology of the migraine attack and mechanisms of action of anti-migraine agents: recent findings in animals].
    Mick G
    Pathol Biol (Paris); 2000 Sep; 48(7):593-607. PubMed ID: 11072637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
    Akerman S; Holland PR; Hoffmann J
    Cephalalgia; 2013 Jun; 33(8):577-92. PubMed ID: 23671254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for the use of 5-HT1-like agonists in the treatment of migraine.
    Feniuk W; Humphrey PP; Perren MJ; Connor HE; Whalley ET
    J Neurol; 1991; 238 Suppl 1():S57-61. PubMed ID: 1646289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Headache and migraine.
    Ziegler DK
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):235-9. PubMed ID: 1320435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
    Peroutka SJ
    Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new triptans.
    Gawel MJ
    Can J Clin Pharmacol; 1999; 6 Suppl A():20A-4A. PubMed ID: 10494008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.
    Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR
    Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sumatriptan: a new approach to migraine.
    Drug Ther Bull; 1992 Oct; 30(22):85-7. PubMed ID: 1330474
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
    Goadsby PJ; Hargreaves RJ
    Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology of migraine: a tentative synthesis.
    Lance JW
    Pathol Biol (Paris); 1992 Apr; 40(4):355-60. PubMed ID: 1379708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.